A new settlement is reached in the Purdue Pharma opioid lawsuit; the US Surgeon General sets out to tackle online health misinformation; Florida poised to enact the state's strictest abortion ban yet.
Purdue Pharma and its owners the Sackler family have reached a $6 billion deal with 9 state attorneys general, up from a previous settlement of $4.5 billion, NPR reports. Purdue Pharma is the maker of OxyContin, an opioid that helped fuel the overdose epidemic in the United States in recent years. The states with the highest overdose death rates in the country, including Oregon, Vermont, and Washington, were among those that demanded more money from the settlement. In a statement, the Sacklers voiced regret but still denied any wrongdoing, while critics have long accused the family of aggressive opioid marketing.
The office of Surgeon General Vivek Murthy, MD, issued a request seeking data from tech companies, health care providers, and community organizations surrounding health misinformation, according to CNN. It is the first time the administration has called on the tech companies to share certain information, including data on major sources of misinformation and who may have been targeted by campaigns, publicly. Murthy has said he wants tech companies to be more transparent and open about sharing data with the public and that the initiative will help researchers better study the impact of misinformation on social platforms.
Lawmakers in Florida have approved the state’s strictest abortion ban yet, which includes no exceptions for victims of rape, incest, or human trafficking, POLITICO reports. Under the measure, which is expected to go into effect on July 1, women will be prohibited from receiving abortions after 15 weeks of pregnancy. Currently, Florida law dictates a woman cannot receive the procedure after 24 weeks of pregnancy. The move comes as states around the country are considering codifying a 15-week ban into law. The Florida law is modeled on a similar one in Mississippi.
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
January 16th 2025An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.
Read More